Jung‐Chen Lin
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- interferon and immune responses
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- SARS-CoV-2 detection and testing
- Viral Infections and Vectors
Papers in
-
- RNA Interference and Gene Delivery 3
-
- Immunotherapy and Immune Responses 5
- interferon and immune responses 2
- Co-authors
- Che‐Ming Jack Hu (11 shared papers)Saborni Chattopadhyay (3 shared papers)Leon C. W. Lin (3 shared papers)Hui‐Wen Chen (4 shared papers)Shuk‐Man Ka (3 shared papers)Ann Chen (3 shared papers)Ching‐Liang Meng (2 shared papers)Kuo‐Feng Hua (2 shared papers)
- Journals
- Nature Communications (2 papers)Advanced Healthcare Materials (2 papers)Gut (2 papers)Nano Letters (1 paper)Arthritis Research & Therapy (1 paper)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Jung‐Chen Lin
21 papers receiving 898 citations
Peers
Comparison fields: 5 of 111
- Immunology 253
- Infectious Diseases 202
- Nephrology 49
- Biomaterials 68
- Biomedical Engineering 200
Countries citing papers authored by Jung‐Chen Lin
This map shows the geographic impact of Jung‐Chen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Chen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Chen Lin more than expected).
Fields of papers citing papers by Jung‐Chen Lin
This network shows the impact of papers produced by Jung‐Chen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Chen Lin. The network helps show where Jung‐Chen Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jung‐Chen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 133 | |
| 2 | 2020 | 114 | |
| 3 | 2015 | 91 | |
| 4 | 2018 | 86 | |
| 5 | 2016 | 78 | |
| 6 | 1995 | 63 | |
| 7 | 1996 | 55 | |
| 8 | 2014 | 48 | |
| 9 | 2019 | 39 | |
| 10 | 2015 | 37 | |
| 11 | 2021 | 33 | |
| 12 | 2023 | 24 | |
| 13 | 2021 | 21 | |
| 14 | 2006 | 21 | |
| 15 | Anomalous intracranial venous drainage associated with basal ganglia calcification. | 2007 | 14 |
| 16 | 2014 | 11 | |
| 17 | 2008 | 10 | |
| 18 | 2023 | 10 | |
| 19 | 2022 | 8 | |
| 20 | 2009 | 6 |
About Jung‐Chen Lin
Jung‐Chen Lin is a scholar working on Molecular Biology, Immunology, Surgery, Infectious Diseases and Oncology, having authored 23 papers that have together received 908 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (5 papers), RNA Interference and Gene Delivery (3 papers), Genetic factors in colorectal cancer (3 papers), interferon and immune responses (2 papers), Cervical Cancer and HPV Research (2 papers), Viral Infections and Vectors (2 papers), SARS-CoV-2 and COVID-19 Research (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Immunology (253 citations), Infectious Diseases (202 citations), Nephrology (49 citations), Biomaterials (68 citations) and Biomedical Engineering (200 citations). Jung‐Chen Lin has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Che‐Ming Jack Hu, Saborni Chattopadhyay, Leon C. W. Lin, Hui‐Wen Chen, Shuk‐Man Ka, Ann Chen, Ching‐Liang Meng, Kuo‐Feng Hua, Louis Kuoping Chao and L F Sheu. Their work appears in journals such as Nature Communications, Advanced Healthcare Materials, Gut, Nano Letters and Arthritis Research & Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.